Sei Investments Co. Decreases Holdings in Chemed Co. (NYSE:CHE)

Sei Investments Co. trimmed its position in shares of Chemed Co. (NYSE:CHE) by 10.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,753 shares of the company’s stock after selling 4,115 shares during the quarter. Sei Investments Co.’s holdings in Chemed were worth $18,414,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. bought a new position in Chemed in the fourth quarter valued at about $42,023,000. HighTower Advisors LLC increased its position in shares of Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock valued at $2,246,000 after purchasing an additional 1,634 shares during the last quarter. XTX Topco Ltd lifted its stake in shares of Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company’s stock worth $1,709,000 after purchasing an additional 1,499 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after buying an additional 15,791 shares during the last quarter. Finally, Signal Advisors Wealth LLC grew its position in Chemed by 60.7% during the fourth quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock valued at $2,647,000 after buying an additional 1,886 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CHE has been the topic of several recent research reports. Royal Bank of Canada increased their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research report on Friday, March 14th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.

Chemed Trading Up 0.5 %

Shares of NYSE:CHE opened at $612.09 on Friday. The stock has a 50 day moving average of $573.14 and a 200 day moving average of $566.47. The company has a market cap of $8.96 billion, a PE ratio of 30.93, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $646.71.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.

Insider Activity

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.